Eli Lilly and Company (LLY)
Add to Watchlists Create an Alert
54.74
-0.18 -0.33%
NYSE
May 23, 8:00PM
BATS Real time
Currency in USD
Eli Lilly and Company Revenue Quarterly YoY Growth:
0.00% for March 31, 2013Eli Lilly and Company Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.00% |
| Dec. 31, 2012 | -1.48% |
| Sept. 30, 2012 | -11.46% |
| June 30, 2012 | -10.43% |
| March 31, 2012 | -4.06% |
| Dec. 31, 2011 | -2.27% |
| Sept. 30, 2011 | 8.72% |
| June 30, 2011 | 8.77% |
| March 31, 2011 | 6.45% |
| Dec. 31, 2010 | 4.26% |
| Sept. 30, 2010 | 1.67% |
| June 30, 2010 | 8.61% |
| March 31, 2010 | 8.69% |
| Dec. 31, 2009 | 14.02% |
| Sept. 30, 2009 | 6.77% |
| June 30, 2009 | 2.76% |
| March 31, 2009 | 4.98% |
| Dec. 31, 2008 | 0.29% |
| Sept. 30, 2008 | 13.58% |
| June 30, 2008 | 11.22% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
LLY Revenue Quarterly YoY Growth Rankings
| Overall |
61st percentile 3086 of 8009 |
| Sector |
53rd percentile 320 of 687 in Healthcare |
| Industry |
61st percentile 21 of 55 in Drug Manufacturers - Major |
LLY Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -11.46% | Sep 2012 |
| Maximum | 14.02% | Dec 2009 |
| Average | 3.55% |
